Impact of Glycemic Control on Penile Duplex Results
1 other identifier
observational
100
0 countries
N/A
Brief Summary
The study aimed at evaluating the impact of glycemic control on the erectile function , penile Doppler, and cavernosal blood NO and glutathione levels among a group of diabetic patients with erectile dysfunction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2025
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 19, 2023
CompletedFirst Posted
Study publicly available on registry
January 24, 2024
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2025
CompletedSeptember 19, 2024
September 1, 2024
Same day
December 19, 2023
September 4, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Penile doppler ultrasound
penile Doppler and measuring cavernosal blood nitric oxide and glutathione levels to compare penile doppler ultrasound brfore and after glycemic control .
Baseline
Cavernosal blood nitric oxide
Comparing cavernosal blood nitric oxide brfore and after glycemic control
Baseline
Cavernosal blood glutathione level
Comparing cavernosal blood glutathione levels brfore and after glycemic control
Baseline
Eligibility Criteria
This prospective observational study will include 100 patients attending our andrology outpatient clinic at Assuit University Hospitals, Egypt, complaining of uncontrolled diabetes mellitus (HBA1C more than 8) and secondary ED for more than 6 months, from October 2023 and over a year. Patients will be included in the study after obtaining a written informed consent and ethical committee approval.
You may qualify if:
- Married Male patients diagnosed with erectile dysfunction.
- Age from 30 to 55 years.
- Documented history of DM.
- Regular sexual life with cooperative wife.
You may not qualify if:
- Patients with congenital anomalies like hypospadius and curvature.
- History of pelvic or spine surgery.
- Single patient.
- Thyroid disorders.
- Other sexual disorders.
- Primary ED.
- History of Peyronie's disease or priapism.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Ahmed Ab Elshibany
Assiut University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident
Study Record Dates
First Submitted
December 19, 2023
First Posted
January 24, 2024
Study Start
January 1, 2025
Primary Completion
January 1, 2025
Study Completion
March 1, 2025
Last Updated
September 19, 2024
Record last verified: 2024-09